These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3404379)

  • 21. Transplacental flecainide therapy for fetal supraventricular tachycardia in a twin pregnancy.
    Edwards A; Peek MJ; Curren J
    Aust N Z J Obstet Gynaecol; 1999 Feb; 39(1):110-2. PubMed ID: 10099764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amiodarone in treatment of fetal supraventricular tachycardia. A case report and review of literature.
    Pradhan M; Manisha M; Singh R; Kapoor A
    Fetal Diagn Ther; 2006; 21(1):72-6. PubMed ID: 16354980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of intermittent tachyarrhythmias in the fetus.
    Simpson JM; Milburn A; Yates RW; Maxwell DJ; Sharland GK
    Pediatr Cardiol; 1997; 18(2):78-82. PubMed ID: 9049114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Refractory fetal supraventricular tachycardia with hydrops: report of one case.
    Wang LW; Wu JM; Lin CS; Lin YJ; Lin CH; Yao BL
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(4):300-3. PubMed ID: 7572177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Successful intrauterine treatment of a supraventricular tachycardia-induced hydrops fetalis with digoxin and verapamil].
    Schwingshandl J; Stein JI; Häusler M
    Wien Klin Wochenschr; 1991; 103(3):73-4. PubMed ID: 2028615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transplacental digoxin therapy for fetal tachyarrhythmia with multiple evaluation systems.
    Zhou K; Hua Y; Zhu Q; Liu H; Yang S; Zhou R; Guo N
    J Matern Fetal Neonatal Med; 2011 Nov; 24(11):1378-83. PubMed ID: 21689050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study.
    Jaeggi ET; Carvalho JS; De Groot E; Api O; Clur SA; Rammeloo L; McCrindle BW; Ryan G; Manlhiot C; Blom NA
    Circulation; 2011 Oct; 124(16):1747-54. PubMed ID: 21931080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fetal supraventricular tachycardia and hydrops fetalis: combined intensive, direct, and transplacental therapy.
    Hallak M; Neerhof MG; Perry R; Nazir M; Huhta JC
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):523-5. PubMed ID: 1870815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transplacental Therapeutic Drug Monitoring in Pregnant Women with Fetal Tachyarrhythmia Using HPLC-MS/MS.
    Starodubtseva N; Kindysheva S; Potapova A; Kukaev E; Khodzhaeva Z; Bockeria E; Chagovets V; Frankevich V; Sukhikh G
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful maternal digoxin therapy of supraventricular tachycardia in a fetus with hydrops.
    Obeidat N; Amarin Z; Obeidat B
    J Obstet Gynaecol; 2008 Nov; 28(8):803-6. PubMed ID: 19085553
    [No Abstract]   [Full Text] [Related]  

  • 31. [Flecaine: drug of choice for supraventricular tachycardias with anasarca. A case report].
    Hamel P; Febbraro W; Barjot P; Lindet Y; Muller G; Iselin M
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(1):37-9. PubMed ID: 9091542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fetal arrhythmias: prenatal evaluation and intrauterine therapeutics.
    Yuan SM; Xu ZY
    Ital J Pediatr; 2020 Feb; 46(1):21. PubMed ID: 32050988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flecainide as first-line treatment for fetal supraventricular tachycardia.
    Ekiz A; Kaya B; Bornaun H; Acar DK; Avci ME; Bestel A; Yildirim G
    J Matern Fetal Neonatal Med; 2018 Feb; 31(4):407-412. PubMed ID: 28114840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia.
    Krapp M; Kohl T; Simpson JM; Sharland GK; Katalinic A; Gembruch U
    Heart; 2003 Aug; 89(8):913-7. PubMed ID: 12860871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Management of hemodynamically significant fetal arrhythmias].
    Hajdú J; Szabó I; Papp C; Görbe E; Cesko I; Papp Z
    Orv Hetil; 1997 Sep; 138(37):2335-8. PubMed ID: 9340581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fetal supraventricular tachycardias: diagnosis and management.
    Simpson LL
    Semin Perinatol; 2000 Oct; 24(5):360-72. PubMed ID: 11071377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intermittent fetal tachycardia and fetal hydrops.
    Smoleniec JS; Martin R; James DK
    Arch Dis Child; 1991 Oct; 66(10 Spec No):1160-1. PubMed ID: 1750769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management outcome and follow-up of fetal tachycardia.
    van Engelen AD; Weijtens O; Brenner JI; Kleinman CS; Copel JA; Stoutenbeek P; Meijboom EJ
    J Am Coll Cardiol; 1994 Nov; 24(5):1371-5. PubMed ID: 7930263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amiodarone therapy for drug-refractory fetal tachycardia.
    Strasburger JF; Cuneo BF; Michon MM; Gotteiner NL; Deal BJ; McGregor SN; Oudijk MA; Meijboom EJ; Feinkind L; Hussey M; Parilla BV
    Circulation; 2004 Jan; 109(3):375-9. PubMed ID: 14732753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrasound recognition and treatment of fetal supraventricular tachycardia with hydrops: a case report.
    Chang CL; Chao AS; Wu CD; Lien R; Cheng PJ
    Changgeng Yi Xue Za Zhi; 1998 Jun; 21(2):217-21. PubMed ID: 9729659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.